HPOL-B 📈 HEXPOL AB (publ) - Overview
Exchange: ST • Country: Sweden • Currency: SEK • Type: Common Stock • ISIN: SE0007074281
HPOL-B: Rubber Compounds, Thermoplastic Elastomers, Thermoplastics, Gaskets, Seals, Wheels
HEXPOL AB (publ) is a global leader in the development, manufacture, and sale of polymer compounds and engineered products, with a presence in Sweden, Europe, the Americas, and Asia. The company's operations are divided into two main segments: HEXPOL Compounding and HEXPOL Engineered Products. The compounding segment focuses on creating customized rubber compounds, including those under the HEXFLAME, HEXLIGHT, GloMold, and other brands, as well as thermoplastic elastomer compounds like Dryflex, Mediprene, and Epseal. Additionally, this segment produces thermoplastic compounds under the RheTech brand, catering to a wide range of applications.
The HEXPOL Engineered Products segment, on the other hand, specializes in manufacturing specialized products such as gaskets for plate heat exchangers and seals under the GISLAVED GUMMI brand. It also produces polyurethane wheels for forklifts under the STELLANA brand, showcasing the company's ability to create high-quality, application-specific products. HEXPOL AB (publ) serves a diverse range of markets, including automotive and transportation, building and construction, consumer and healthcare, energy, wire and cable, industrial, oil and gas, rollers, gaskets, and seals and wheels. With a rich history dating back to 1893, the company is headquartered in Malmö, Sweden, and has established itself as a key player in the specialty chemicals industry.
As a company with a long history and a strong presence in the global market, HEXPOL AB (publ) has developed a robust product portfolio and a significant customer base. Its commitment to innovation and quality has enabled the company to maintain its competitive edge and expand its operations across different regions. With its web presence at https://www.hexpol.com, the company provides easy access to information about its products, services, and operations. Listed with the ISIN SE0007074281 as a common stock, HEXPOL AB (publ) falls under the GICS Sub Industry category of Specialty Chemicals, further highlighting its specialized focus and expertise in the chemical industry.
Additional Sources for HPOL-B Stock
HPOL-B Stock Overview
Market Cap in USD | 3,402m |
Sector | Basic Materials |
Industry | Specialty Chemicals |
GiC Sub-Industry | Specialty Chemicals |
IPO / Inception |
HPOL-B Stock Ratings
Growth 5y | 31.3% |
Fundamental | 68.4% |
Dividend | 78.0% |
Rel. Strength Industry | -8099 |
Analysts | - |
Fair Price Momentum | 101.40 SEK |
Fair Price DCF | 173.12 SEK |
HPOL-B Dividends
Dividend Yield 12m | 5.84% |
Yield on Cost 5y | 7.91% |
Annual Growth 5y | 9.86% |
Payout Consistency | 94.1% |
HPOL-B Growth Ratios
Growth Correlation 3m | 36.1% |
Growth Correlation 12m | -56.9% |
Growth Correlation 5y | 84.3% |
CAGR 5y | 6.27% |
CAGR/Mean DD 5y | 0.51 |
Sharpe Ratio 12m | -0.62 |
Alpha | -34.74 |
Beta | 0.86 |
Volatility | 26.85% |
Current Volume | 532.1k |
Average Volume 20d | 632.8k |
As of December 21, 2024, the stock is trading at SEK 103.00 with a total of 532,106 shares traded.
Over the past week, the price has changed by -6.03%, over one month by +0.69%, over three months by -7.55% and over the past year by -12.07%.
Yes, based on ValueRay Fundamental Analyses, HEXPOL AB (publ) (ST:HPOL-B) is currently (December 2024) a good stock to buy. It has a ValueRay Fundamental Rating of 68.35 and therefor a positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of HPOL-B as of December 2024 is 101.40. This means that HPOL-B is currently overvalued and has a potential downside of -1.55%.
HEXPOL AB (publ) has no consensus analysts rating.
According to ValueRays Forecast Model, HPOL-B HEXPOL AB (publ) will be worth about 111.7 in December 2025. The stock is currently trading at 103.00. This means that the stock has a potential upside of +8.48%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 125.7 | 22% |
Analysts Target Price | - | - |
ValueRay Target Price | 111.7 | 8.5% |